Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Oncology|July 6, 2019
Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone DeacetylaseJeonghun Han, Wanyoung Lim, Daeun You, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 8, 2018
Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer CellsSangmin Kim, Jeongmin Lee, Daeun You, et al.Oncotarget|September 9, 2017
Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 inductionMyeongjin Jeon, Daeun You, Soo Youn Bae, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 18, 2016
Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expressionSangmin Kim, Jeonghun Han, Myeongjin Jeon, et al.Oncology Reports|April 13, 2021
Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cellsDaeun You, Yisun Jeong, Sun Young Yoon, et al.Cytokine|August 1, 2020
WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cellsSangmin Kim, Daeun You, Yisun Jeong, et al.Biomedicines|March 29, 2023
Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer CellsSangmin Kim, Hyungjoo Kim, Yisun Jeong, et al.Cells|January 10, 2025
Induction of SUSD2 by STAT3 Activation Is Associated with Tumor Recurrence in HER2-Positive Breast CancerYisun Jeong, Hyungjoo Kim, Daeun You, et al.Molecules (Basel, Switzerland)|July 2, 2021
Entelon® (Vitis vinifera Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer CellsDaeun You, Yisun Jeong, Sun Young Yoon, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 1, 2019
EGFR is a Therapeutic Target in Hormone Receptor-Positive Breast CancerYisun Jeong, Soo Youn Bae, Daeun You, et al.Pageof 3